Clarivate (CLVT) is a buy as 1Q25 marks a turning point with organic growth, stronger renewals, and a robust revenue mix.

Shareholders will be ecstatic, with their stake up 23% over the past week following Clarivate Plc's (NYSE:CLVT) latest first-quarter results. The results don't look great, especially considering that ...

Q1 2025 Earnings Call Transcript April 29, 2025 Operator: Thank you for joining. And ladies and gentlemen, my name is Karen.

the platform combines the robust search capabilities of Procedure Finder with the extensive Clarivate provider and affiliations network. It delivers real-world, data-driven intelligence ...

Shares of Clarivate climbed after the company beat Wall Street's expectations for revenue and adjusted earnings in the first quarter and maintained its full-year outlook. The stock rose 15% to $4.12.

Clarivate, which has headquarters in London, said in February it was exploring strategic alternatives including potential ...

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG Commercial Analytics 360—a solution designed to empower medtech companies with ...